Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation
Open Access
- 1 December 2004
- journal article
- letter
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (12) , 883-884
- https://doi.org/10.1016/j.bbmt.2004.09.004
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Practical Management of Patients With Chronic Myeloid Leukemia Receiving ImatinibJournal of Clinical Oncology, 2003
- Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantationBlood, 2002
- Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaBlood, 1992